DaShenLin Pharmaceutical Group Co (SHSE:603233) Other Operating Expense : ¥858 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is DaShenLin Pharmaceutical Group Co Other Operating Expense?

DaShenLin Pharmaceutical Group Co's Other Operating Expense for the three months ended in Mar. 2024 was ¥0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥858 Mil.

DaShenLin Pharmaceutical Group Co's quarterly Other Operating Expense increased from Sep. 2023 (¥-380 Mil) to Dec. 2023 (¥844 Mil) but then declined from Dec. 2023 (¥844 Mil) to Mar. 2024 (¥0 Mil).

DaShenLin Pharmaceutical Group Co's annual Other Operating Expense increased from Dec. 2021 (¥604 Mil) to Dec. 2022 (¥823 Mil) and increased from Dec. 2022 (¥823 Mil) to Dec. 2023 (¥861 Mil).

DaShenLin Pharmaceutical Group Co Other Operating Expense Historical Data

The historical data trend for DaShenLin Pharmaceutical Group Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaShenLin Pharmaceutical Group Co Other Operating Expense Chart

DaShenLin Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

388.35

480.52

603.89

822.99

860.90

DaShenLin Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															3.25	393.46	-380.01	844.19	0.38

DaShenLin Pharmaceutical Group Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥858 Mil.

DaShenLin Pharmaceutical Group Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of DaShenLin Pharmaceutical Group Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

DaShenLin Pharmaceutical Group Co (SHSE:603233) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DaShenLin Pharmaceutical Group Co Ltd (SHSE:603233) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 410-1, Longxi Avenue, Liwan District, Guangdong Province, Guangzhou, CHN, 510000

Website

http://www.dslyy.com

DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.

DaShenLin Pharmaceutical Group Co (SHSE:603233) Headlines

No Headlines